Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Involvement of Krüppel-like Factors in Cardiovascular Diseases. | Life (Basel) | 2023 | 36836777 | PubTator, text mining | PubMed |
| Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs. | Int J Mol Sci | 2023 | 36835184 | PubTator, text mining | PubMed |
| Mitochondrial Homeostasis in VSMCs as a Central Hub in Vascular Remodeling. | Int J Mol Sci | 2023 | 36834896 | PubTator, text mining | PubMed |
| Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers. | Int J Mol Sci | 2023 | 36834728 | PubTator, text mining | PubMed |
| Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy. | Int J Mol Sci | 2023 | 36834660 | PubTator, text mining | PubMed |
| Endometrial Inflammation and Impaired Spontaneous Decidualization: Insights into the Pathogenesis of Adenomyosis. | Int J Environ Res Public Health | 2023 | 36834456 | PubTator, text mining | PubMed |
| Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer. | Cells | 2023 | 36831341 | PubTator, text mining | PubMed |
| Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma. | Biomolecules | 2023 | 36830767 | PubTator, text mining | PubMed |
| Sarcopenia: Molecular regulatory network for loss of muscle mass and function. | Front Nutr | 2023 | 36819699 | PubTator, text mining | PubMed |
| Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitus. | Ann Transl Med | 2023 | 36819540 | PubTator, text mining | PubMed |
| Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review). | Oncol Lett | 2023 | 36817052 | PubTator, text mining | PubMed |
| BTYNB, an inhibitor of RNA binding protein IGF2BP1 reduces proliferation and induces differentiation of leukemic cancer cells. | Saudi J Biol Sci | 2023 | 36816728 | PubTator, text mining | PubMed |
| Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer. | Front Oncol | 2023 | 36814821 | PubTator, text mining | PubMed |
| Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. | Mol Cancer | 2023 | 36810098 | PubTator, text mining | PubMed |
| Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer. | BMC Med | 2023 | 36810084 | PubTator, text mining | PubMed |
| Hypoxia-Induced FUS-circTBC1D14 Stress Granules Promote Autophagy in TNBC. | Adv Sci (Weinh) | 2023 | 36806670 | PubTator, text mining | PubMed |
| New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy. | Semin Cancer Biol | 2023 | 36806560 | PubTator, text mining | PubMed |
| Retraction notice to "LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy" [Life Sci. 266 (2021) 118794]. | Life Sci | 2023 | 36804895 | PubTator, text mining | PubMed |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. | Gynecol Oncol | 2023 | 36804622 | PubTator, text mining | PubMed |
| circRNA-ZCCHC14 affects the chondrogenic differentiation ability of peripheral blood-derived mesenchymal stem cells by regulating GREM1 through miR-181a. | Sci Rep | 2023 | 36804426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=32